Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - eplerenone - film coated tablet - 50 milligram - aldosterone antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - eplerenone - film coated tablet - 25 milligram - aldosterone antagonists

Ireland - English - HPRA (Health Products Regulatory Authority)

clear pharmacy - eplerenone - film coated tablet - 25 milligram - aldosterone antagonists

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - eplerenone - film-coated tablet - eplerenone 25 mg - diuretics

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - eplerenone - film-coated tablet - eplerenone 50 mg - diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - eplerenone - film coated tablet - 25 milligram - eplerenone - aldosterone antagonists - in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular (cv) mortality and morbidity in stable patients with left ventricular dysfunction (lvef
40 %) and clinical evidence of heart failure after recent myocardial infarction (mi). in addition to standard optimal therapy, to reduce the risk of cardiovascular mortality and morbidity in adult patients with new york heart association (nyha) class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef
30%)

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - eplerenone - film coated tablet - 50 milligram - eplerenone - aldosterone antagonists - eplerenone is indicated: in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular (cv) mortality and morbidity in stable patients with left ventricular dysfunction (lvef
40 %) and clinical evidence of heart failure after recent myocardial infarction (mi). addition to standard optimal therapy, to reduce the risk of cardiovascular mortality and morbidity in adult patients with new york heart association (nyha) class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef
30%)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - eplerenone - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - eplerenone - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - eplerenone - oral tablet - 50mg